Physician profile
Jonathan C Freeman
NPI 1679869275
$1,301.69
in general payments reported to CMS, 2019-2025
18 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $34.14 · 2021: $64.06 · 2022: $178 · 2023: $384 · 2024: $27.72 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $214.73 | 2019-2025 | Acessa Provu System |
| Abbvie INC. | $183.09 | 2019-2025 | |
| Astellas Pharma US INC | $164.21 | 2023-2025 | Veozah, Myrbetriq |
| Change Healthcare Technologies, LLC | $136.67 | 2019 | |
| Merck Sharp & Dohme LLC | $134.23 | 2019-2025 | Gardasil 9 |
| Intuitive Surgical, INC. | $98.67 | 2023 | Da Vinci Surgical System |
| Coopersurgical, INC. | $82.94 | 2019-2023 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $62.62 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $52.61 | 2025 | Myfembree |
| Biogen, INC. | $32.63 | 2025 | Zurzuvae |
| Baxter Healthcare | $23.97 | 2023 | Tisseel |
| Glaxosmithkline, LLC. | $20.75 | 2022 | |
| Daiichi Sankyo INC. | $17.20 | 2019 | |
| Organon LLC | $17.19 | 2022 | |
| Evofem Biosciences, INC. | $16.83 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $16.80 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.30 | 2019 | |
| Agile Therapeutics, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.